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Transplant approach establishes that kidneys are responsible for
serum CSF-1 but require a stimulus in MRL-lpr mice. Colony stimulating
factor-i (CSF-i) is a chemoattractant and growth factor for macrophages.
In autoimmune MRL-lpr mice, CSF-1 is detected in the circulation and
there is an increase in CSF-i transcripts and macrophages in the kidney.
The purpose of this study was to establish whether the MRL-lpr kidney is
responsible for increasing serum CSF-1, and to determine if the expression
of CSF-i requires a circulating component in MRL-lpr mice. We trans-
planted a MRL-lpr kidney with nephritis [serum CSF-i = 32.6 5.1
colony forming units (CFU)] into a bilaterally nephrectomized normal
MRL-+ + recipient. Circulating CSF-1 increased from 1.2 0.5 CFU to
14.1 5.6 CFU in recipients by one week. Continuous production of
CSF-i required a stimulating component since: (1) CSF-l in the kidney
and circulation disappeared several weeks after eograftment into
MRL- + + mice and (2) isolated glomeruli from MRL-lpr required stim-
ulation to express CSF-i. In the transplanted MRL-lpr kidney, hypercel-
lularity in the glomerulus and interstitium (predominantly macrophages)
returned to normal as rapidly as two weeks after engraftment into
MRL- + +. Thus, this study establishes that the kidney is responsible for
circulating CSF-1 in MRL-lpr mice. Without the autoimmune environ-
ment CSF-i, macrophages, but oat T cells, disappear and nephritis
resolves.
Colony stimulating factor-i (CSF-i) is a hematopoietic cyto-
kine that is a chemoattractant [11, growth and differentiation
factor for maerophages [21. We previously reported a biphasic
increase of circulating CSF-i in autoimmune MRL/MPJ-lpr/lpr
(MRL-lpr) mice which develop a fatal lupus nephritis [3]. CSF-1 is
detected in the circulation of neonates and peaks at one week of
age (first phase), reaches a nadir at two months of age, and
reascends in proportion to the degree of renal injury (second
phase). In previous studies, we determined that the kidney was
probably responsible for increasing circulating CSF-i levels dur-
ing the second phase because we identified a marked increase in
CSF-i transcripts in kidneys, but not in other tissues including
lymph node, spleen, liver, lung and bone marrow of MRL-lpr mice
[3]. We detected enhanced CSF-1 transcripts in the renal glomcr-
uli [4], and reported that mesangial cells expressed CSF-i in
MRL-lpr mice [5]. In addition, we localized lesser amounts of
CSF-i expression in tubular epithelial cells and vascular smooth
muscle cells. These transcripts were present prior to the onset of
renal disease (1 to 2 months of age) and increased with the loss of
renal function (3 to 5 months of age) in MRL-lpr mice [5].
Furthermore, we have established that macrophages which accu-
mulate in glomeruli of MRL-lpr mice are dependent on CSF-1 for
survival and proliferation [4]. Most importantly, using a gene
transfer system we also determined that introduction of CSF-i
into MRL-lpr, but not MRL- + +, mice induces renal injury
(manuscript in preparation). The purpose of the present study was
to design a renal transplant model to establish whether the
MRL-lpr kidney could secrete a sufficient amount of CSF-1 to
persistently maintain the elevated levels of circulating CSF-i.
Additionally, we wished to determine whether the production of
CSF-1 was constitutive or dependent on a stimulus contributed by
another component in the MRL-lpr strain, and whether the
glomerular, interstitial and perivascular lesions characteristic of
this strain resolve without renal CSF-1. Thus, our transplant
system allowed us to place a kidney from an autoimmune mouse
strain into a congenic normal recipient, and to explore the
capacity of the donor kidney overexpressing a cytokine to con-
tinue to generate this molecule. In this study, we transplanted a
single MRL-lpr kidney (4 months of age) into a bilaterally
nephrectomized age-matched normal MRL/MpJ-+ + (MRL-+ +)
mouse. This congenic MRL- + + strain lacking the lpr gene does
not have circulating CSF-i, serologic abnormalities, or renal
pathology during the first year of life. Based on these studies, we
now report that the kidneys are responsible for secreting the
majority, if not all, of the CSF-i detected in the circulation of
MRL-lpr mice, and requires another circulating component to
induce CSF-i production. Using this transplant system, we note
that the increased cellularity in the glomeruli and the interstitium
of the donor MRL-lpr kidney rapidly returns to normal after
engraftment, and is accompanied by the loss of CSF-i expression
and macrophages. By comparison, there is no apparent decrease
in the perivascular infiltrates which are predominantly composed
of T cells. Finally, in the absence of CSF-1 and macrophages
within the glomeruli and interstitium, the autoimmune glomerular
and interstitial nephritis resolves.
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Mice
Autoimmune MRL-lpr (H-2") and normal MRL-+ + (H-2")
and C3H/FeJ (H-2') mice were obtained from The Jackson
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Laboratory (Bar Harbor, ME, USA). All animals were main-
tained in our animal facility on standard laboratory chow.
Reagents
Tissue culture media and reagents were purchased from Gibco
(Grand Island, NY, USA). Lipopolysaccharide (LPS) was pur-
chased from Calbiochem (La Jolla, CA, USA). 2-Mercaptoetha-
nol (2-ME) was purchased from Sigma (St. Louis, MO, USA).
Polyclonal rabbit anti-mouse L cell-derived CSF-1 was provided
by Dr. R. Shadduck (Monteflore Hospital, Pittsburgh, PA, USA),
and polyclonal rabbit anti-human CSF-1 was provided by Genetics
Institute (Cambridge, MA, USA). Monoclonal antibody for F4180
antigen was obtained from American Tissue Culture Collection
and purified by affinity chromatography of supernatants over
protein A-Sepharose CL-4B columns (Pharmacia, Piscataway, NJ,
USA).
Transplantation of MRL-lpr kidney into bilaterally nephrectomized
MRL-++ mice
We transplanted either a single female MRL-lpr or MRL- + +
kidney removed from mice four months of age into bilaterally
nephrectomized age-matched male MRL- + + mice as previously
described [6]. Briefly, animals were anesthetized with isoflurane
and the donor kidney, ureter, and bladder were harvested en bloc,
including the renal artery with a small aortic cuff and the renal
vein with a small caval cuff. These vascular cuffs were anasto-
mosed to the recipient abdominal aorta and vena cava, respec-
tively, below the level of the native renal vessels. Total ischemic
time averaged 35 to 40 minutes. Donor and recipient bladders
were attached dome to dome. The right native kidney was
removed at the time of transplantation (Tx) and the left native
kidney was removed through a flank incision four days later.
Blood was obtained by cardiac puncture before Tx and 1, 2, 4, 6
weeks, and 4 to 7 months post-Tx, respectively, for the determi-
nation of circulating CSF-1 by colony stimulating assay. Blood
samples were allowed to clot at 4°C, centrifuged, and the sera
were stored frozen until use.
Evaluation of renal pathology and immunohistochemical detection
of renal macrophages and CSF-1
We examined kidney specimens taken from the recipient
MRL-++ mice 1,2, 4, 5, 6 weeks, and 4 months post-Tx from the
donor MRL-lpr mice, and histopathologically compared them
with the donor contralateral kidney or the recipient kidney
removed at the time of Tx. Kidney sections for light microscopic
evaluation were fixed with 10% buffered formalin, paraffin-
embedded, and stained with hematoxylin and eosin by a standard
procedure. Tissue for immunoperoxidase staining were directly
snap-frozen in OCT (Miles Scientific, Naperville, IL, USA) and
stored in —80°C. Using a light microscope we counted the cells in
intra- and periglomerular areas of 20 randomly selected glomeruli
and described them as cells/glomerulus. Interstitial mononuclear
cells were counted in 10 randomly selected fields of cortical
interstitium under a light microscope (x400) and described them
as cells/field. Perivascular cell infiltration was evaluated in 10
inter- and intralobular arteries, and graded by counting the
number of cell layers surrounding the vessel: 0, none; 1, <5 layers
surrounding < 50% of the vessel; 2, 5 to 10 layers surrounding>
50% of the vessel; 3, >10 layers. All slides were analyzed by two
individuals using coded slides. Furthermore, we located macro-
phages in the kidney by the presence of F4/80 antigen using the
immunoperoxidase technique. Immunoperoxidase staining was
carried out by the avidin-biotin complex method as previously
described [5]. Briefly, fixed sections were blocked with 0.1%
sodium azide and 0.3% H202 for 10 minutes, treated with bovine
testicular hyaluronidase (1 mg/mI) in 0.1 M sodium acetate at 37°C
for 30 minutes, and blocked with avidin/biotin blocking kit
(Vector Laboratories, Burlingame, CA, USA) for 15 minutes.
Sections were incubated with normal rabbit serum for 30 minutes,
and then with diluted F4/80 mAb (5 .tg/ml) for two hours at room
temperature, washed in 0.1% bovine serum albumin containing
Tris buffer (pH 7.6), and then incubated with biotinylated rabbit
anti-rat immunoglobulin for one hour. This was followed by a one
hour incubation with the avidin-biotin-horseradish peroxidase
complex (Vectastatin ABC reagent, Vector Laboratories). Perox-
idase activity was detected after a five minute incubation with
3,3'-diaminobenzidine, 0.5 mg/ml containing 0.03% H202. Sec-
tions were then rinsed and counterstained with methyl-green/
alcian blue, Glomerular macrophages were evaluated by counting
cells expressing F4/80 in intra- and periglomerular areas of 20
randomly selected glomeruli, and interstitial macrophages were
counted by the same method used for counting interstitial mono-
nuclear cells. Perivascular macrophages were evaluated in 10
inter- and intralobular arteries and the % of macrophages in total
perivascular cellular infiltrates were calculated. In addition, we
evaluated CSF-1 expression within the kidney by immunoperoxi-
dase staining using polyclonal rabbit anti-human CSF-1 antibody
(10 g/ml). Sections (10 jim) were cut from frozen blocks and
fixed in 95% ethanol for five minutes. Immunoperoxidase staining
was carried out by the avidin-biotin complex method as described
above.
CSF-1 production by isolated glomeruli
Isolation of glomeruli was performed as previously described
[5]. Briefly, anesthetized MRL-lpr, MRL-+ + and C3H/FeJ mice
were perfused through a 25 gauge butterfly needle cannulated
into the left ventricle. Kidneys were perfused with heparinized
Hanks' balanced salt solution (HBSS) while simultaneously
transecting the inferior vena cava above the level of hepatic vein.
Kidneys were then removed and cortices were cut away and
minced into ito 2 mm pieces, and then passed through a series of
steel sieves (250, 150 and 75 m, W.S. Tyler Inc., Mentor, OH,
USA), with glomeruli being retained in the final sieve. After
washing this glomeruli-enriched preparation of about 85% purity
with HBSS containing 5% fetal calf serum (FCS, Hyclone, Logan,
UT, USA) twice, glomeruli were reconstituted in 3 ml of Dulbec-
co's modified Eagle's medium (DMEM) with 10% FCS, 1%
penicillin and streptomycin. Glomeruli were counted and 3500
glomeruli in 500 jsl medium were incubated in 24-well plates at
37°C in a humidified 5% CO2 atmosphere with or without LPS (1
tg/ml). After 72 hours of incubation, 100 d of culture superna-
tant was collected for the determination of CSF-1 using the colony
stimulating assay.
Colony stimulating assay
We assessed CSF-1 in sera and culture supernatants as previ-
ously described [7]. Briefly, bone marrow cells were obtained from
the tibias of C3H/FeJ mice. One X 10 bone marrow cells were
added to 30 j.d of test serum or 100 p1 of culture supernatant and
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Table 1. Transplanted MRL-lpr kidney is responsible for an increase in circulating CSF-1 in recipient MRL-+ + mice
Donor
Recipient (MRL-+ +)
CFU
Pre-Tx
Post-Tx
CFU 1 week 2 weeks 4 weeks 6 weeks 4-7 months
MRL-lpr 1 26.0 (2)° 0 13.0 6.0 8.0 0 0
2 21.0 5.5 15.0 15.0 (2) 2.0 (2) 4.5 ND
3 31.0 0 — 16.0 0 ND ND
4 24.5 0 7.0 ND ND ND ND
5 49.0 (1)° 1.0 13.0 (2)° ND ND ND ND
6 44.0 (l)U 1.0 — 16.0 (1)° ND ND ND
7 — 0 8.5 5.0 — 0 ND
8 — 2.0 6.5 4.0 ND ND ND
9 — 1.5 1.0 6.5 ND ND ND
10 — 0 49.0 22.0 0 — 0
11 — 2.0 — 4.0 5.0 ND ND
32.6 5.1 1.2 0.5 14.1 5.6" 10.5 2.4" 3.0 1.8 1.5 1.8 0 0
MRL-++ 1 0 0 1.5 0.5 ND ND ND
2 0 0 0 ND ND ND ND
3 0 0 0 ND ND ND ND
0±0 0±0 0.5±0.9 0.5 — — —
Abbreviations are: Tx, transplantation; ND, not determined, because recipient mice did not survive.
a Neutralized with anti-mouse CSF-1
bP < 0.05 vs. recipient pre-Tx value
plated in 1 ml 0.3% Noble agar (Difco, Detroit, MI, USA) in
McCoy's 5A medium supplemented with 15% FCS, 50 jimol
2-ME, 10 U/ml penicillin and 10 jig/mi streptomycin in 35 mm
tissue culture plates (Costar, Cambridge, MA, USA). Cultures
were incubated at 37°C in a humidified 5% CO2 atmosphere and
the colonies were counted on day 10 with a dissecting microscope.
We report the results of colony stimulating assays as colony
forming units (CFU) per io bone marrow cells. This assay has a
limit of detection of 50 units of CSF-1, based on determination of
CFU using murine recombinant CSF-1. For inhibition studies, 30
j.tl of test sera or 100 ,al of supernatants were preincubated with 30
jil of various dilutions of either polyclonal rabbit anti-mouse L
cell-derived CSF-1 or normal rabbit serum for 30 minutes at room
temperature before assay. The specificity of CSF-1 in the serum or
supernatant was tested by preincubation with CSF-1-containing L
cell supernatant, recombinant murine granulocyte-macrophage
colony-stimulating factor (Genzyme, Cambridge, MA, USA), and
murine recombinant interleukin-3 (Biogen, Cambridge, MA,
USA). Positive control serum for this assay was obtained from
C3H/FeJ male mice injected with 10 jig of LPS subcutaneously
and bled six hours later (58 CFU). Previous data from our
laboratory indicate that peak induction of CSF-1 after LPS
injection occurs at six to eight hours and is absent by 18 to 24
hours [3].
Statistical analysis
Data are shown by means SE. The colony stimulating assay
was done in at least duplicated samples. Statistical significance
was determined by use of ANOVA.
Results
Transplanted MRL-lpr kidney is responsible for increasing
circulating CSF-1
Transplantation of a single MRL-lpr kidney (4 months of age)
into an age-matched bilaterally nephrectomized MRL- + + recip-
ient increased CSF-1 in the circulation (Table 1). In recipient
MRL-+ + mice, CSF-1 was barely detectable (1.2 0.5 CFU)
prior to receiving the transplanted kidney. By comparison, circu-
lating CSF-1 levels increased to 14.1 5.6 CFU one week
post-Tx, and remained elevated for an additional week (10.5 2.4
CFU, at week 2 post-Tx). The amount of CSF-1 produced by the
transplanted MRL-lpr kidney was approximately one half the
amount of CSF-1 measured in the circulation of the donor. To
eliminate the possibility that the surgical procedure induced
CSF-1 production, we transplanted a single MRL-+ + kidney into
a bilaterally nephrectomized MRL-++ recipient. We did not
detect an increase in circulating CSF-1 levels 1 or two weeks after
MRL- + + recipients received the MRL- + + kidney (0.5 0.9, 0.5
CFU, respectively, Table 1). However, circulating CSF-1 in the
MRL-+ + recipients diminished to nearly undetectable levels (3.0
1.8 CFU) four weeks after receiving the donor MRL-lpr kidney,
and was no longer detectable six weeks post-Tx. In addition,
CSF-1 expression in the MRL-lpr kidney disappeared following
engraftment into recipient MRL-++ mice. The donor MRL-lpr
kidney had abundant CSF-1 expression primarily in the glomeruli
and to a lesser degree in the interstitium (Fig. 1A). In the
transplanted MRL-lpr kidney after one week, we could barely
detect CSF-1 in the glomeruli and the interstitium (Fig. 1B). Four
weeks post-Tx, the expression of CSF-1 in the transplanted kidney
became indistinguishable from the recipient kidney which did not
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Fig. 1. Glomerular and interstitial expression of
CSF-1 in transplanted MRL-lpr kidneys decreased
one week post-engraftinent. In the donor MRL-
lpr kidney, four months of age, the expression
of CSF-1 was most pronounced in glomerular
mesangial area (arrowheads) and in the
interstitial cells (arrows) (A). In the
transplanted MRL-lpr kidney one week post-
engraftment into MRL-+ + mouse, CSF-1 was
barely detectable in glomeruli (arrowheads) and
interstitium (arrows) (B). (Immunoperoxidase
staining. x500)
express CSF-1. This loss of CSF-1 expression in the glomeruli and
interstitium was consistent with the decline of CSF-1 in the
circulation generated by the engrafted kidney.
MRL-lpr glomeruli require primaty stimulation to secrete CSF-1
We measured CSF-1 activity in culture supernatants of isolated
glomeruli, with or without LPS stimulation. Glomeruli isolated
from MRL-lpr mice did not release detectable amounts of CSF-1
without stimulation by LPS (Table 2). LPS (1 agIml) induced
CSF-1 secretion as detected in culture after 72 hours. Glomeruli
isolated from MRL-lpr mice three months of age secreted less
CSF-1 after LPS stimulation as compared to glomeruli isolated
from MRL-Ipr mice four to nine months of age (P = 0.04). To
determine whether there are any differences in CSF-1 production
by glomeruli isolated from different mouse strains, we also
evaluated CSF-1 activity in supernatants of cultured glomeruli
isolated from MRL-+ + or C3H/FeJ mice three months of age,
with or without LPS stimulation. Glomeruli isolated from
MRL-++ mice did not secrete detectable CSF-1 after 72 hours of
incubation without LPS stimulation, but LPS induced similar
Table 2. MRL-lpr glomeruli require stimulation to secrete CSF-1
Age
Strain months N LPS CFU
MRL-lpr 33
4—9
4—9
3
3
3
3
—
+
—
0±0
27±3a
0±0
433a,b
MRL-++ 3
3
3
3 +
0±035±r
a P < 0.01 vs. without LPS
bP C 0.05 vs. MRL-lpr 3 months of age
amounts of CSF-l as compared with glomeruli isolated from
age-matched MRL-lpr mice. LPS also induced a secretion of
similar increased proportion of CSF-1 in glomeruli isolated from
C3H/FeJ (data not shown). The level of CSF-1 induced by LPS
was proportionally similar in three mouse strains in three re-
peated experiments, and similar data were obtained in experi-
ments at either 24 or 48 hours after incubation with LPS.
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Table 3. Glomerular and interstitial infiltrates, but not perivascular infiltrates in donor MRL-Ipr kidney decreased 2 weeks after transplanting into
MRL-++ mice
Kidney N
Glomerular-intra Glomerular-peri Interstitial
cells/field"
Perivascular
Grade of infiltrates"cells/glom"
Pre-Tx
Donor MRL-lpr
Recipient MRL-++
4
4
54 4
41 3"
60 6
20 2"
83 10
22 2"
2.0 0.3
0.4 0.2"
Post-Tx week
1 2 47±3 54±4 78±8 2.0±0.3
2 2 40 3" 28 2" 42 5" 1.9 0.2
4 2 39±2" 24"-l" 366d 1.8±0.3
5 1 41 2" 25 2" 38 7" 1.9 0.3
6 1 38 3" 23 2" 32 8" 2.1 0.3
16 2 41 4" 26 3" 28 7" 2.2 0.2
Tx is transplantation.
and periglomerular cells were counted in randomly selected 20 glomeruli
hMononuclear infiltrates in cortical interstitium were counted in 10 randomly selected fields (X400)
Perivascular infiltrates were evaluated in ramdomly selected 10 inter- and intralobular arteries and graded as follows: 0, none; 1, <5 layers
surrounding <1/2 circle of the vessel; 2, 5—10 layers surrounding >1/2 circle of the vessel; 3, >10 layers surrounding the vessel.dP < 0.05 vs. donor MRL-lpr kidney.
Glomerular and interstitial nephritis of the engrafted MRL-lpr
kidney is ameliorated post-Tx in the MRL- + + recipient
When a kidney from a donor MRL-lpr mouse four months of
age was transplanted into a MRL-+ + recipient, the renal pathol-
ogy was evaluated in the remaining contralateral kidney of the
MRL-lpr donor. A severe mesangioproliferative glomerulonephri-
tis was detected, as well as a periglomerular, interstitial and
perivascular mononuclear cell infiltration in the donor contralat-
eral kidney (Table 3, Fig. 2A). The intra- and periglomerular total
cell counts were 54 4, 60 6 cells/glomerulus, respectively
(Table 3). The transplanted MRL-lpr kidney evaluated one week
post-Tx had proliferative glomerulonephritis in which intra- and
periglomerular cell counts (47 3, 54 4 cells/glomerulus) were
similar to those seen in donor contralateral kidney evaluated at
the time of Tx. In contrast, as rapidly as two weeks post-Tx, the
numbers of intra- and periglomerular cells decreased to 40 3, 28
2 cells/glomerulus, respectively. Therefore, the numbers of cells
in the glomeruli were fewer than those in the donor contralateral
kidneys and equivalent to those in recipient MRL-++ kidneys.
The improvement of glomerular hypercellularity and periglo-
merular cell infiltration was even more evident in the transplanted
MRL-lpr kidney evaluated 4, 5 and 6 weeks, and 4 months post-Tx
(Fig. 2, Table 3). Similarly, the numbers of cells infiltrating the
interstitium declined by two weeks post-Tx and decreased further
to normal by six weeks post-Tx (Table 3). In contrast, perivascular
cell infiltration were similar in the donor contralateral kidney and
the transplanted kidney (Table 3).
Macrophages disappear from the glomeruli and
interstitium post-Tx
We determined whether the disappearance of macrophages was
responsible for the decreased cellularity in the glomeruli and
interstitium after Tx. The numbers of macrophages in the glomer-
uli (pen- and intra-) and interstitium of the MRL-lpr kidney
decreased two weeks post-engraftment (Table 4) and corre-
sponded with the reduction in total cellularity in each location
(Table 3). In donor contralateral kidneys, glomerular (pen- and
intra-) macrophages were 30 3/glomerulus. In the transplanted
MRL-lpr kidney evaluated one week post-Tx, the numbers of
glomerular macrophages were similar to those in donor kidneys
(26 3/glomerulus). In contrast, at two weeks post-Tx glomerular
macrophages dramatically decreased (9 2/glomerulus). Gb-
merular macrophages decreased further 4, 5 and 6 weeks, and 4
months post-Tx (2 1, 1 1, 3 1, 4 2/glomerulus,
respectively). The numbers of gbomerular macrophages in the
MRL-lpr mice before and at 1 and 4 weeks post-Tx had a high
positive correlation with glomerular CSF-1 expression; the corre-
lation coefficient was 0.84 (P < 0.05), and 0.99 (P < 0.01),
respectively. It is interesting to note that T cells were rarely
detected in the glomeruli and only a small number (< 25%) were
present in the periglomerular infiltrates. Similarly, interstitial
macrophages decreased by two weeks post-Tx (56 8/field =
donor, 19 3/field = transplanted kidney; Table 4). This reduc-
tion in macrophages was responsible for 90% of the decreased
interstitial cellularity. We were unable to detect a decrease in the
macrophages in the penivascular area of the transplanted kidneys
as compared with the donor contralateral kidneys (5 to 10% in
each kidney). This may be related to the vast majority (90%) of
these infiltrates being T cells.
Discussion
We have established a renal transplant system to explore the
contribution of the autoimmune environment to the expression of
cytokines in the kidney of MRL-lpr mice. We transplanted the
kidney with progressive nephritis from an autoimmune mouse
strain into a congenic normal mouse strain and determined
whether CSF-1 production caused an increase in serum CSF-l. In
addition, we established whether an inherent defect in the kid-
ney or a circulating component in the autoimmune strain induced
this molecule. Furthermore, using this strategy we were able to
determine whether the continuance of progressive renal injury
required a component in the autoimmune mice.
We now report that the kidney of the MRL-lpr mice produces
sufficient CSF-1 to be responsible for an increase in circulating
levels. The intercapillary cells in glomeruli express the vast
majority of CSF-1 and probably are responsible for most of the
serum levels. Since the intercapillary area consists of mesangial
cells which have the capacity to produce CSF-1 [5] and to a lesser
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Fig. 2. Glomerulonephritis in the MRL-lpr kidney is ameliorated after transplantation into the recipient MRL- + + mouse. The donor MRL-lpr kidney (4
months of age) had a severe mesangioproliferative glomerulonephritis, and mononuclear cell infiltration in periglomerular area (A). In the transplanted
kidney two weeks (B) or four months (C) post-engraftment into the MRL-+ + mice, the proliferative change in glomeruli and periglomerular infiltrates
were no longer evident, and the glomeruli appeared similar to the 4-month-old MRL-+ + kidney (D). (Hematoxylin and eosin. x500)
degree macrophages, and since macrophages of MRL-lpr mice do
not produce CSF-l [3], it can be concluded that the mesangial
cells of MRL-lpr are the primary renal source of this cytokine. We
also conclude that continuous production of CSF-1 requires a
stimulating component. This concept is based on the loss of CS F-i
in the transplanted MRL-lpr kidney and in the circulation shortly
(1 week) after being placed in the MRL-++ strain, and inability
of isolated glomeruli from MRL-lpr kidneys to produce CSF-1
without stimulation.
The induction of CSF-1 could result from a molecule either in
the circulation or released by infiltrating cells. There are many
components including circulating molecules and cells identified in
the serum of MRL-lpr, but not in the congenic MRL-+ + strain,
which could be responsible for inducing CSF-1. Perhaps the best
candidate is TNF-s, since TNF-cs stimulates CSF-1 production by
monocytes and mesangial cells [5, 8, 9]. Furthermore, we previ-
ously reported a biphasic increase of circulating TNF-a levels in
MRL-lpr mice, which paralleled the levels of CSF-1 in the
circulation [10]. This enhanced TNF-a may be produced by the
massive numbers of abnormal double negative (CD4CD8 ) as
well as in single positive (CD4 or CD8) T cells in MRL-lpr mice
[111. In addition to TNF-a, there is an age-associated increase in
serum interleukin-6 (IL-6) in MRL-/pr mice that is absent in the
MRL-++ strain [12, 13]. IL-6 is known to enhance CSF-1
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Table 4. Glomerular and interstitial macrophages in MRL-lpr kidney
decreased 2 weeks post-engraftment into MRL-+ + mice
Kidney N
Glomerular'
cells/glom
Interstitial
cells/field
Pre-Tx
Donor MRL-lpr
Recipient MRL-++
4
4
30 34 2h 56 88 2b
Post-Tx week
1 2 26±3 46±7
2 2 9÷21, 193b
4 2 2÷1b ii±5
5 1 11b 9±3h
6 1 3±ih 124h
16 2 4±2k 13±6
Tx is transplantation.
a Intra- and periglomerular macrophages
P < 0.05 vs. donor contralateral kidney
expression in human fibroblasts by transcriptional and post-
transcriptional mechanisms [14]. Thus, IL-6 could also be respon-
sible for increasing CSF-1. Additionally, circulating immunoglob-
ulin (IgG) complexes may contribute to renal CSF-1 production.
In support of this concept, hyperfunction of B lymphocytes is a
prominent pathological feature in MRL-lpr, not present in con-
genie MRL-+ + mice, and a high frequency of immunoglobulin-
secreting cells in MRL-lpr mice is amplified with progressive renal
injury [15]. Since IgG complexes can stimulate the generation of
CSF-1 by mouse mesangial cells [16], circulating IgG molecules
could certainly be stimulating CSF-1 production in MRL-lpr
kidneys. However, it is unlikely that IgG is the only stimulus since
other strains with the lpr mutation have an increase in circulating
IgG levels, yet they do not have elevated serum CSF-1 [3]. Finally,
interferon-y (IFN-y) also has the capacity to induce CSF-1. We
and others have reported that the CD4CD8 T cells in the
MRL-lpr kidney produce IFN-y [17, 18]. Furthermore, IFN-y can
induce mesangial cells to secrete CSF-1 [9]. Although it is unclear
whether IFN-y is present in the circulation of MRL-lpr mice,
circulating IFN-y has been reported in patients with systemic
lupus erythematosus with active disease [19]. Indeed, one or
several of these components may participate in the intrarenal
induction of CSF-1.
Macrophages derived from MRL-lpr mice have the capacity to
induce tissue destruction as reflected by increased generation of
reactive oxygen intermediates and enhanced production of prom-
flammatory eicosanoids [20, 21]. Therefore, macrophages which
accumulate in the MRL-lpr kidney prior to the loss of renal
function have the capacity to induce tissue destruction. At two
weeks post-engraftment the numbers of macrophages in the
glomeruli and interstitium of the engrafted MRL-lpr kidney
dramatically decline. This finding is consistent with our prior
studies in which glomerular macrophages were incapable of
proliferating and surviving without a continual supply of CSF-1
[4]. Since renal CSF-1 production disappears several weeks post-
engraftment, it is not surprising that macrophages no longer
survive in the transplanted kidney. The dissapearance of macro-
phages is accompanied by a resolusion of glomerular and inter-
stitial pathology. The only renal pathologic change that did not
resolve was the pronounced perivascular infiltration of cells,
consisting almost exclusively of T cells and containing relatively
few (5 to 10%) macrophages. It is interesting that these T cells
survived and remained in the transplanted kidney after placement
in a non-autoimmune host. Thus, the decrease in glomerular and
interstitial cellularity was restricted to the macrophages. Taken
together, these data suggest that the removal of CSF-1 would
deplete the presence of macrophages in glomeruli and intersti-
tium and in turn halt the progression of renal injury. Clearly,
additional studies will determine if removal of renal CSF-1 in
humans is a useful therapeutic approach to limiting autoimmune
renal injury.
In summary, we have established an experimental system that
can explore the donor's versus the recipient's contribution of a
transplanted kidney to cytokine production, regulation as well as
renal injury. Using this novel approach, we have clearly estab-
lished that the kidney is responsible for increasing circulating
CSF-1 in MRL-lpr mice, but it requires another circulating
component for continuous CSF-1 production. We are currently
extending our studies to identify those components in the serum
involved in stimulating CSF-1. Furthermore, we have established
that in the absence of components in the circulation of MRL-/pr
mice, macrophages in the glomeruli and interstitium do not
survive and renal disease not only fails to progress, but rapidly
resolves.
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